Article Sidebar

PDF
Date Published: 11/04/2022
Abstract Views: 113
Views PDF: 87
DOI: https://doi.org/10.60117/vjmap.v43i2.93
Issue
Vol. 43 No. 2 (2022)
Section
Research Articles
How to Cite
Phạm, T. P., Phạm, Q. B., & Nguyễn, T. T. (2022). Evaluate the anti-atherosclerotic effect Of “ha mo nk” capsule on patients with dyslipidemia. Viet Nam Journal of Traditional Medicine and Pharmacy, 43(2), 71-78. https://doi.org/10.60117/vjmap.v43i2.93

Evaluate the anti-atherosclerotic effect Of “ha mo nk” capsule on patients with dyslipidemia

Thủy Phương Phạm, Quốc Bình Phạm, Trọng Thông Nguyễn

Main Article Content

Abstract

Objectives: The study aimed to evaluate the effectiveness of treatment of dyslipidemia and anti-atherosclerotic effects of the "Ha mo NK" capsule on a number of subclinical indicators. Investigate the undesirable effects of the “ Ha mo NK” capsule.


Research subjects and methods: Patient has been diagnosed with “痰”: Phlegm-induced dyslipidemia.


The study was conducted according to the open clinical trial method, comparing before and after treatment and compared with the control group.


Results: "Ha mo NK" capsule reduced AI by 27.57%, CRI by 22.39% and AIP by 52.95%, equivalents to


the patients group using Atorvastatin 10mg, reduced AI by 28.18%, CRI by 22.81% and AIP by 74.99%.


Conclution: "Hamo NK" capsule have the effect of regulating blood lipid indexes andhaveanti-atherosclerotic effects on patients with dyslipidemia and haven’t undesirable effects during treatment.

Article Details

Keywords

Dyslipidemia, “Ha mo NK” capsule.

References

1. Bộ Y tế (2015), Rối loạn chuyển hóa lipid máu, Hướng dẫn chẩn đoán và điều trị bệnh nội tiết - chuyển hóa, Nhà xuất bản Y học, tr.255-264.
2. Catapano AL, et al. (2016), “ESC/EAS Guidelines for the Management of Dyslipidaemias”, European Heart Journal (2016) 37, 2999–3058 doi:10.1093/eurheartj/ehw272.
3. National Cholesterol Education Program (NCEP) Expert Panel (2002), “Third report of the National Cholesterol Education Program (NCEP) EXpert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report”, Circulation, 106(25), pp. 3143-3421.
4. 中華人民共和國衛生部.中藥新藥臨床研究指導則.北京: 中國醫藥科技出版社, (2002): Bộ Y tế CHND Trung Hoa (2002). Nguyên tắc chỉ đạo nghiên cứu lâm sàng về Trung-Tân dược, NXB Khoa học kỹ thuật Y dược Trung Quốc, tr. 86.